NADAL® Nuclear Matrix Protein 22 Test

$155.91

In stock

  • Qualitative detection of NMO22 in urine samples
  • Rapid test for bladder cancer screening
  • Test result can be read after approx. 15 minutes
  • Simple visual interpretation without additional devices
  • 10 test cassettes and 10 disposable pipettes

Best By: January 1, 1970

Purchase this product now and earn 156 Points!

NADAL® Nuclear Matrix Protein 22 Test

The NADAL® Nuclear Matrix Protein 22 (NMP22) Test from nal von Minden is a reliable in-vitro immunoassay for the qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA) in urine. This professional rapid test offers doctors a simple and hygienic method for bladder cancer screening and monitoring, with results available in approximately 15 minutes.

Product Details

  • NADAL® Nuclear Matrix Protein 22 from nal von Minden
  • Reliable and hygienic in-vitro immunoassay
  • Qualitative detection of Nuclear Mitotic Apparatus Protein (NuMA)
  • Professional rapid test for bladder cancer screening
  • Applicable for monitoring as well
  • Sample material: Urine
  • Detected parameter: Nuclear Matrix Protein 22
  • Results readable in about 15 minutes
  • Simple visual interpretation without additional devices
  • Includes integrated procedural control
  • Storage at room temperature (2-30 °C)
  • CE marked
  • Includes 10 disposable pipettes and a user manual
  • 10 tests

Performance Characteristics

To obtain data on diagnostic sensitivity and specificity, urine from 32 patients with biopsy-confirmed bladder cancer and 112 healthy individuals without bladder tumours was tested with the NADAL® Nuclear Matrix Protein 22 Test. The results are shown in the table below:

Only logged in customers who have purchased this product may leave a review.

Reviews

There are no reviews yet.

Click to access the login or register cheese

Main Menu

NADAL® Nuclear Matrix Protein 22 Test

x  Powerful Protection for WordPress, from Shield Security
This Site Is Protected By
ShieldPRO